Patents by Inventor Jonathan Ostrem

Jonathan Ostrem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20240067656
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: October 19, 2023
    Publication date: February 29, 2024
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Compositions and methods for treating cancer
    Patent number: 11891402
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: February 6, 2024
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Compositions and methods for treating cancer
    Patent number: 11718630
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: October 27, 2022
    Date of Patent: August 8, 2023
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20230242548
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: November 23, 2022
    Publication date: August 3, 2023
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20230135350
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: October 27, 2022
    Publication date: May 4, 2023
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Compositions and methods for treating cancer
    Patent number: 11603376
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: March 25, 2021
    Date of Patent: March 14, 2023
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20210230183
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: March 25, 2021
    Publication date: July 29, 2021
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Compositions and methods for treating cancer
    Patent number: 11008334
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: May 18, 2021
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20200255446
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: December 19, 2019
    Publication date: August 13, 2020
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20190119295
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: June 20, 2018
    Publication date: April 25, 2019
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • Compositions and methods for treating cancer
    Patent number: 10023588
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: July 17, 2018
    Assignee: The Regents of the University of California
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20160368930
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: November 6, 2015
    Publication date: December 22, 2016
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20150087628
    Abstract: K-Ras is the most frequently mutated oncogene in human cancer. Disclosed herein are compositions and methods for modulating K-Ras and treating cancer.
    Type: Application
    Filed: April 10, 2013
    Publication date: March 26, 2015
    Inventors: Jonathan Ostrem, Ulf Peters, Kevan M. Shokat